Susanne Muehlschlegel MD, MPH
|Institution||University of Massachusetts Medical School|
|Address||University of Massachusetts Medical School|
55 Lake Avenue North
Worcester MA 01655
|Institution||UMMS - School of Medicine|
|Institution||UMMS - School of Medicine|
|Germany||1995||German Chemical Industry Award (Outstanding Achievement, Chemistry Major), German Chemical Industry |
|Studienstiftung des Deutschen Volkes||1995
||2002||Studienstiftung des Deutschen Volkes (German National Merit) Scholarship |
|University of Florida||2004||Neuroscience Resident Teacher of the Year|
|University of Florida||2005||Neurology Resident Teacher of the Year|
|University of Florida||2006||Neurology Resident Teacher of the Year|
|University of Florida College of Medicine||2006||Alpha Omega Alpha (Staff Member)|
|American Academy of Neurology||2006||American Academy of Neurology Neurobowl® Resident team player|
|University of Massachusetts||2009||Clinical Excellence Award “Organ Donation”|
|University of Massachusetts ||2010||Clinical Excellence Award “Acute Stroke Team Member”|
|UMASS Medical School||2010||WFBR Grant, http://www.umassmed.edu/focus/052010/wfbr_grants.aspx|
|University of Massachusetts ||2011||Clinical Excellence Award “Organ Donation”|
|University of Massachusetts Medical School||2011
||2012||Faculty Scholar Award (awarded to women faculty at UMASS Medical School for outstanding research)|
|American Academy of Neurology||2012
||2014||Councilor, Executive Committee of the Critical Care and Emergency Neurology Section |
|Neurocritical Care Society||2013||Presidential Citation for Outstanding Contributions to Neurocritical Care|
|Neurocritical Care Society||2013
||2017||Board of Directors|
Dr. Muehlschlegel completed clinical training in neurology, vascular neurology and neurocritical care, and is triple board certified in these subspecialties. She has obtained additional research training through the completion of the Harvard School of Public Health Summer Program for Clinical Effectiveness and Masters of Public Health Program, with a focus in Clinical Effectiveness. During fellowship, under the mentorship of neurointensivist, translational scientist and director of neurocritical care at Massachusetts General Hospital (MGH), John R. Sims, MD, she became initially engaged in cerebral vasoconstriction syndromes and studying dantrolene as a novel means for prevention and treatment of cerebral vasospasm after subarachnoid hemorrhage, as well as in the reversible vasoconstriction syndrome “Call-Fleming-Syndrome”. Her work was funded by the American Heart Association Scientist Development Grant, and the 2010 Worcester Research Foundation, and results of her investigator initiated feasibility trial of Dantrolene after subarachnoid hemorrhage is in prepartion for publication. Supported by the University of Massachussetts Medical School (UMASS) Faculty Scholar award (to support women in research during times of increased family responsibilities), she turned to her passion: improving the outcome prognostication of moderate-severe traumatic brain injury admitted to the neurointensive care unit. Mentored by senior epidemiologist Robert Goldberg, PhD, she is studying the longitudinal course of critically ill TBI patients, creating new prediction tools, and demonstrating the variability of outcome prognostication by clinicians. She is currently interested in developing shared decision making tools, which may ultimately limit uninformed withdrawal of care or futile prolongation of life decisions by families and physician biases (http://informedmedicaldecisions.org/what-is-shared-decision-making). This work is in line with the Patient Protection and Affordable Care Act of 2010 which supports a national shared decision making program http://www.nejm.org/doi/full/10.1056/NEJMp1209500.
Dr. Muehlschlegel and her colleague Dr. Carandang are the co-founders of the New England Neurocritical Care Research Consortium (NENCC), a regional consortium consisting of MGH, UMASS, BWH, Boston Medical Center, Yale, Baystate Medical Center and Rhode Island Hospital, with the goal of facilitating collaborative multi-center research in neurocritical care.
Dr. Muehlschlegel is the co-chair of the Neurocritical Care Society Website Committee (www.neurocriticalcare.org), and member of the newsletter editorial board. Since 2013, she has been an elected member of the Board of Directors of the Neurocritical Care Society, and is currently serving a 4-year term. The Neurocritical Care Society is the largest international multidisciplinary neurocritical care professional society dedicated to improve the health care and outcomes of patients with life-threatening neurological illnesses by promoting quality patient care, professional collaboration, research, training and advocacy.
Dr. Muehlschlegel is a well-recognized teacher. She has been was actively involved in daily teaching of medical students and residents in neurology and other disciplines since residency. As a chief resident she organized bi-weekly neurology board review sessions, as well as other regular teaching conferences and journal clubs. As a fellow, her teaching efforts continued, and involved daily resident education sessions during or after rounds on acute stroke and neurointensive care issues. She initiated a combined lecture series of surgical ICU and neuro-ICU fellows. She was actively involved as a lecturer at the ACLS course for health care providers at MGH. As a UMASS faculty member, Dr. Muehlschlegel is currently responsible for the supervision of surgical critical care fellows, residents, medical students and mid-level providers (PA/ARNP) in the trauma and neuro-ICU. She established a regular bi-weekly teaching lecture series for the mid-level providers specialized in neuro-ICU. She gives lectures regularly to neurology, emergency medicine, anesthesia and surgery residents. When on service in the ICU, she provides teaching to the ICU team with all its members during the daily SICU morning lectures. She teaches all ICU procedures as well as all clinical aspects of neurocritical care. She has been co-director of the UMASS Department of Neurology/Neuroscience Journal Club since 2008.
As a neurointensivist, Dr. Muehlschlegel is one of only approximately 500 U.S. board certified subspecialists in this field. She is involved in the direct care of critically ill neurology, neurosurgery and trauma patients. She managed all neuroICU and general surgical ICU problems, including but not limited to ventilators, hemodynamics, sepsis, nutrition, electrolyte imbalances, acid-base disorders, infections, and ventriculostomies. She is known to communicate very effectively and empathetically with family members and establishes great rapport with patients and affected families.
Post-Graduate Medical and Research Training:
2002-2006 -- Neurology Residency, University of Florida
2005-2006 -- Chief Resident (Neurology), University of Florida
2006-2008 -- Neurocritical Care and Vascular Neurology Fellowship, Massachusetts General Hospital and Brigham & Women's Hospital, Harvard Medical School
2007-2010 -- Masters of Public Health (Clinical Effectiveness), Harvard School of Public Health
Lab rotations are available for undergraduate and medical students, residents and fellows. Visiting students from abroad should inquire about visa requirements first before applying.
For assistance with using Profiles, please refer to the online tutorials
or contact UMMS Help Desk
or call 508-856-8643.
Click the "See All" links for more information and interactive visualizations!
People who are also in this person's primary department.